.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Johnson and Johnson
Healthtrust
Deloitte
Cipla
Farmers Insurance
Boehringer Ingelheim
Express Scripts
AstraZeneca
Baxter

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021097

« Back to Dashboard
NDA 021097 describes VISICOL, which is a drug marketed by Salix Pharms and is included in one NDA. Additional details are available on the VISICOL profile page.

The generic ingredient in VISICOL is sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate. There are one thousand three hundred and seventy-nine drug master file entries for this compound. Additional details are available on the sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate profile page.

Summary for NDA: 021097

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.398GM;1.102GM
Approval Date:Sep 21, 2000TE:RLD:No

Expired Orange Book Patents for NDA: 021097

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Salix Pharms
VISICOL
sodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate
TABLET;ORAL021097-001Sep 21, 20005,616,346► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Cipla
Citi
Mallinckrodt
Julphar
Daiichi Sankyo
Accenture
AstraZeneca
Medtronic
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot